3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Urinary Incontinence, Urge: new trials by email Literature Review of Urinary Incontinence, Urge trials Research Report on Urinary Incontinence, Urge
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder Bryophyllum - Overactive Bladder, Urge Urinary Incontinence | Phase 2 / Phase 3 | Terminated | University of Zurich | 9 | 2014-05-01 | 2017-10-26 |
| Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity AV608 - Overactive Bladder Syndrome | Phase 2 | Terminated | Avera Pharmaceuticals | 62 | 2006-06-01 | 2008-02-25 |
| Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients GW679769 - Incontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder | Phase 2 | Terminated | GlaxoSmithKline | 1 | 2006-01-01 | 2015-04-17 |
Urinary Bladder, Overactive (3) · Spinal Cord Injuries (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Lower Urinary Tract Symptoms (3) · Male Urogenital Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urinary Bladder Diseases (3) · Urinary Incontinence (3) · Urination Disorders (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Urological Manifestations (3) · Central Nervous System Diseases (1) · Nervous System Diseases (1) · Spinal Cord Diseases (1)
casopitant (1)
Avera Pharmaceuticals (1) · GlaxoSmithKline (1) · University of Zurich (1)
Netherlands (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Joao Siffert, MD (1) · Linda Cardozo, MD FRCOG (1)